A method for preparing a stable immunogenic product comprising antigenic heterocomplexes of TNFalpha and a carrier protein

Details for Australian Patent Application No. 2006284248 (hide)

Owner Neovacs

Inventors Zagury, Daniel; Le Buanec, Helene

Agent Watermark

Pub. Number AU-B-2006284248

PCT Pub. Number WO2007/022813

Priority 05300404.0 24.05.05 EP

Filing date 24 May 2006

Wipo publication date 1 March 2007

Acceptance publication date 7 October 2010

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

Event Publications

20 December 2007 PCT application entered the National Phase

  PCT publication WO2007/022813 Priority application(s): WO2007/022813

7 October 2010 Application Accepted

  Published as AU-B-2006284248

3 February 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006284258-An apparatus for circumcising a penis

2006284245-Process for producing articles having an electrically conductive coating